AN UNIDENTIFIED, FILTRABLE AGENT ISOLATED FROM TRANSPLANTED HUMAN TUMORS.
作者信息
Toolan H W, Dalldore G, Barclay M, Chandra S, Moore A E
机构信息
SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH, NEW YORK CITY.
出版信息
Proc Natl Acad Sci U S A. 1960 Sep;46(9):1256-8. doi: 10.1073/pnas.46.9.1256.
Abstract
摘要
相似文献
1
AN UNIDENTIFIED, FILTRABLE AGENT ISOLATED FROM TRANSPLANTED HUMAN TUMORS.从移植的人类肿瘤中分离出的一种未鉴定的可滤过性因子。
Proc Natl Acad Sci U S A. 1960 Sep;46(9):1256-8. doi: 10.1073/pnas.46.9.1256.
2
An Unidentified, Filtrable Agent Isolated From the Feces of Children With Paralysis.从麻痹儿童粪便中分离出的一种不明可滤过性因子。
Science. 1948 Jul 16;108(2794):61-2. doi: 10.1126/science.108.2794.61.
3
Filtrable virus-like agent isolated from tumors induced by carcinogenic substances.
Folia Biol (Praha). 1962 Feb;8:7-11.
4
[Significance of various biological factors in the action of the filtrable agent from mouse tumors].
Strahlentherapie. 1957;15(Sonderbd. 37):116-7.
5
Filtrable forms of mycobacteria tuberculosis.
Z Erkr Atmungsorgane. 1984;162(2):147-54.
6
IDENTIFICATION OF THE FILTRABLE, TRANSMISSIBLE NEUROLYTIC AGENT ISOLATED FROM TOXOPLASMA-INFECTED TISSUE AS A NEW PLEUROPNEUMONIA-LIKE MICROBE.从感染弓形虫的组织中分离出的可滤过、可传播的神经溶解因子被鉴定为一种新型类胸膜肺炎微生物。
Science. 1938 Dec 16;88(2294):575-6. doi: 10.1126/science.88.2294.575.
7
[Specific agent inducing rheumatism. I. Certain data on filtrable virus isolated in rheumatism].
Ter Arkh. 1958 May;30(5):3-15.
8
A filtrable agent producing lymphoid tumors and osteopetrosis in chickens.
Cancer Res. 1946 Apr;6:189-96.
9
Tumor induction in Swiss mice by filtrable agent and Salmonella typhimurium.
Acta Med Okayama. 1979 Oct;33(5):405-7.
10
[Filtrable forms of Bact. breslau. I. Method of obtaining and regeneration of filtrable forms].
Mikrobiol Zh. 1955;17(2):7-10.
引用本文的文献
1
Mapping the sialic acid-binding sites of LuIII and H-1 parvovirus.绘制LuIII和H-1细小病毒的唾液酸结合位点图谱。
J Virol. 2025 Aug 19;99(8):e0029725. doi: 10.1128/jvi.00297-25. Epub 2025 Jul 24.
2
The Complex Role of Infectious Agents in Human Cutaneous T-Cell Lymphoma Pathogenesis: From Candidate Etiological Factors to Potential Therapeutics.感染因子在人类皮肤T细胞淋巴瘤发病机制中的复杂作用：从候选病因到潜在治疗方法
Pathogens. 2024 Feb 20;13(3):184. doi: 10.3390/pathogens13030184.
3
An Extensive Review on Preclinical and Clinical Trials of Oncolytic Viruses Therapy for Pancreatic Cancer.溶瘤病毒疗法治疗胰腺癌的临床前和临床试验综述
Front Oncol. 2022 May 24;12:875188. doi: 10.3389/fonc.2022.875188. eCollection 2022.
4
Small but mighty: old and new parvoviruses of veterinary significance.小而强大：具有兽医意义的新旧细小病毒。
Virol J. 2021 Oct 24;18(1):210. doi: 10.1186/s12985-021-01677-y.
5
Parvovirus-Based Combinatorial Immunotherapy: A Reinforced Therapeutic Strategy against Poor-Prognosis Solid Cancers.基于细小病毒的联合免疫疗法：一种针对预后不良实体癌的强化治疗策略。
Cancers (Basel). 2021 Jan 19;13(2):342. doi: 10.3390/cancers13020342.
6
Cancer Treatment Goes Viral: Using Viral Proteins to Induce Tumour-Specific Cell Death.癌症治疗引发热潮：利用病毒蛋白诱导肿瘤特异性细胞死亡。
Cancers (Basel). 2019 Dec 7;11(12):1975. doi: 10.3390/cancers11121975.
7
H-1 Parvovirus as a Cancer-Killing Agent: Past, Present, and Future.H-1 微小病毒作为一种癌症杀伤剂：过去、现在和未来。
Viruses. 2019 Jun 18;11(6):562. doi: 10.3390/v11060562.
8
Tumor Selectivity of Oncolytic Parvoviruses: From in vitro and Animal Models to Cancer Patients.溶瘤细小病毒的肿瘤选择性：从体外和动物模型到癌症患者。
Front Bioeng Biotechnol. 2015 Apr 22;3:55. doi: 10.3389/fbioe.2015.00055. eCollection 2015.
9
Structural characterization of H-1 parvovirus: comparison of infectious virions to empty capsids.H-1 细小病毒的结构特征：感染性病毒粒子与空衣壳的比较。
J Virol. 2013 May;87(9):5128-40. doi: 10.1128/JVI.03416-12. Epub 2013 Feb 28.
10
Simian parvoviruses: biology and implications for research.猴细小病毒：生物学特性及其对研究的意义
Comp Med. 2008 Feb;58(1):47-50.
本文引用的文献
1
Experimental production of mongoloid hamsters.蒙古仓鼠的实验性培育
Science. 1960 May 13;131(3411):1446-8. doi: 10.1126/science.131.3411.1446.
2
Observations on the heterologous transplantation of human tumors.
Cancer Res. 1958 May;18(4):485-7.
3
Zotero 插件